Showing results (1321-1330 of 1,787) with videos related to
Sort By:
Pageof 179
Hepatology Communications|July 22, 2026
Contemporary global epidemiology of cirrhosisPreenapun Saokhieo, Thanida Auttapracha, Pojsakorn Danpanichkul, et al.Hepatology Communications|July 20, 2026
LECT2 deficiency contributes to bile acid metabolic reprogramming and cholestatic liver injuryWenbo Shi, Luze Cen, Jing Huang, et al.Hepatology Communications|July 17, 2026
The role of ammonia in chronic liver diseaseAnnarein J C Kerbert, Maria Pilar Ballester, Christopher F Rose, et al.Hepatology Communications|July 22, 2026
Extended haplotypes at the complement factor H gene locus are associated with liver transplant rejectionLianne M Nieuwenhuis, Bao-Li Loza, Stefan P Berger, et al.Hepatology Communications|July 17, 2026
Circulating multi-omic signature of disease severity and cholangiocarcinoma in primary sclerosing cholangitisGhada Nouairia, Adam Schumacher, Annika Bergquist, et al.Hepatology Communications|August 1, 2026
Manufacturing and electrostatic surface optimization of CAR-T cells improve therapeutic efficacy in liver malignanciesLinke Bian, Jiufei Zhu, Hongye Wang, et al.Hepatology Communications|July 28, 2026
Global multicenter validation of noninvasive fibrosis assessment pathways in MetALD and ALDHyundam Gu, Luis Antonio Díaz, Natalia Baeza, et al.Hepatology Communications|July 17, 2026
Vitamin D supplementation is associated with reduced risk of hepatobiliary malignancy in patients with primary sclerosing cholangitisKatherine M Cooper, Connor Mulligan, Henry E Pratt, et al.Hepatology Communications|August 7, 2026
Challenges in the care of rare vascular liver diseases: Insights from patients, health care providers, and patient organizationsMercedes Guilabert, Agnes Dumas, Eva Gil-Hernández, et al.Hepatology Communications|August 7, 2026
Spatiotemporal dynamics of the tumor microenvironment in hepatocellular carcinoma during combination immunotherapyHitoshi Iwasaki, Shinji Itoh, Katsuya Toshida, et al.Pageof 179